A-Top Health Biotech Co., Ltd. (TPEX:7686)
Taiwan · Delayed Price · Currency is TWD 983.00
+181.00 (22.57%)
At close: Sep 7, 2026
A-Top Health Biotech Market Cap
A-Top Health Biotech has a market cap or net worth of 49.26 billion as of September 4, 2026.
Market Cap
49.26B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
983.00
ChartMarket Cap Chart
Since August 31, 2026, A-Top Health Biotech's market cap has increased from 26.06B to 49.26B, an increase of 89.04%. That is a compound annual growth rate of 26,309,719,991,092,756.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 49.26B | 22.57% |
| Sep 4, 2026 | 40.19B | 33.67% |
| Sep 3, 2026 | 30.07B | 23.71% |
| Sep 2, 2026 | 24.30B | -3.96% |
| Sep 1, 2026 | 25.31B | -2.88% |
| Aug 31, 2026 | 26.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 34.99B |
| HanchorBio | 19.66B |
| Elixiron Immunotherapeutics (Cayman) Limited | 18.66B |
| Intelligene | 8.09B |
| Uwell Biopharma | 7.21B |
| Tripartite Therapeutics | 4.73B |
| Obigen Pharma | 4.01B |
| Pet Pharm Biotech | 3.42B |